<DOC>
	<DOC>NCT00601302</DOC>
	<brief_summary>The objective of this study was the bioequivalence of a Roxane Laboratories' Amlodipine Besylate tablets, 10 mg, to NorvascÂ® Tablets, 10 mg (Pfizer) under fed conditions using a single-dose, randomized, 2-treatment, 2-period, 2-sequence crossover design.</brief_summary>
	<brief_title>Bioequivalency Study of Amlodipine Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina, Stable</mesh_term>
	<mesh_term>Angina Pectoris, Variant</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening. Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to Amlodipine Besylate or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>